Douglas Goodin, MS, MD

Director of the Multiple Sclerosis Center

Dr. Douglas Goodin is a neurologist and an internationally renowned expert on multiple sclerosis (MS).

Goodin divides his time between patient care, clinical research and teaching. His research focuses on understanding genetic and environmental aspects of MS epidemiology as well as on developing and assessing new treatments for MS.

Goodin earned his medical degree at the University of California, Irvine. He then completed a residency in neurology and fellowship training in clinical electrophysiology at UCSF. He also has a master's degree in molecular biology from Purdue University.

Goodin is a professor of neurology at UCSF.

Clinics

Multiple Sclerosis Center
1500 Owens St., Suite 320
San Francisco, CA 94158
Phone: (415) 353-2069
Fax: (415) 353-2633

Hours: Monday to Friday
8 a.m. – 5 p.m.

Academic Title

Professor

More about Douglas Goodin

Education

Purdue University , M.S., Molecular Biology 1973
University of California, Irvine 1978

Residencies

UCSF, Neurology 1982

Fellowships

UCSF, Clinical Electrophysiology

Selected Research and Publications

  1. Goodin DS, Reder AT, Traboulsee AL, Li DK, Langdon D, Cutter G, Cook S, O'Donnell T, Kremenchutzky M, Oger J, Koelbach R, Pohl C, Wicklein EM. Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b. Mult Scler. 2018 May 01; 1352458518773511.
  2. Goodin DS, Mitsikostas DD. Reply to Tsivgoulis and colleagues comments. Mult Scler Relat Disord. 2018 Apr; 21:120-121.
  3. Goodin DS, Khankhanian P, Gourraud PA, Vince N. Highly conserved extended haplotypes of the major histocompatibility complex and their relationship to multiple sclerosis susceptibility. PLoS One. 2018; 13(2):e0190043.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.